Factors influencing activated clotting time following heparin administration for the initiation of cardiopulmonary bypass. 2021

Satoshi Matsushita, and Akinori Kishida, and Yoshihito Wakamatsu, and Hiroshi Mukaida, and Hirohide Yokokawa, and Taira Yamamoto, and Atsushi Amano
Faculty of Medicine, Department of Cardiovascular Surgery, Juntendo University, 2-1-1, Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan. saty-m@juntendo.ac.jp.

OBJECTIVE Initiation of cardiopulmonary bypass (CPB) for open-heart surgery requires that heparin be administered and reach an adequate value of activated clotting time (ACT). We previously introduced a new heparin formula that considered the preoperative ACT. In this study, we determined other factors affecting ACT. METHODS Adult patients who underwent cardiac surgery using CPB were divided into two groups according to their ACT value after the initial administration of heparin during surgery. ACT above 450 s was defined as "Reach", and this group was compared to the "Short" group with ACT below 450 s. RESULTS The Reach and Short groups included 334 (64.7%) and 182 (35.3%) cases, respectively. Univariate analysis indicated that preoperative heparin use, age ≥ 80 years, New York Heart Association classification 4, white blood cell counts above the higher limit, hematocrit below the lower limit, platelet cell counts below the lower limit, low albumin levels, moderate renal dysfunction, high C-reactive protein levels, high brain natriuretic peptide levels, and moderate deterioration of left ventricular ejection fraction were associated with the effects of heparin. Multivariate analysis revealed that age ≥ 80 years (odds ratio [OR] 2.53, 95% confidence interval [95%CI] 1.41-5.24), New York Heart Association classification 4 (OR = 4.44, 95%CI 1.59-15.35), and platelet count below the lower limit (OR 0.37, 95%CI 0.31-0.85) were associated with the effects of heparin. CONCLUSIONS Old age, heart failure, and lower platelet counts affected heparin activity. The dose of heparin should be considered in those patients to reach the target ACT.

UI MeSH Term Description Entries
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D013318 Stroke Volume The amount of BLOOD pumped out of the HEART per beat, not to be confused with cardiac output (volume/time). It is calculated as the difference between the end-diastolic volume and the end-systolic volume. Ventricular Ejection Fraction,Ventricular End-Diastolic Volume,Ventricular End-Systolic Volume,Ejection Fraction, Ventricular,Ejection Fractions, Ventricular,End-Diastolic Volume, Ventricular,End-Diastolic Volumes, Ventricular,End-Systolic Volume, Ventricular,End-Systolic Volumes, Ventricular,Fraction, Ventricular Ejection,Fractions, Ventricular Ejection,Stroke Volumes,Ventricular Ejection Fractions,Ventricular End Diastolic Volume,Ventricular End Systolic Volume,Ventricular End-Diastolic Volumes,Ventricular End-Systolic Volumes,Volume, Stroke,Volume, Ventricular End-Diastolic,Volume, Ventricular End-Systolic,Volumes, Stroke,Volumes, Ventricular End-Diastolic,Volumes, Ventricular End-Systolic
D014914 Whole Blood Coagulation Time The time required by whole blood to produce a visible clot. Activated Coagulation Time, Whole Blood,Blood Coagulation Time, Whole,Coagulation Time, Whole Blood
D016277 Ventricular Function, Left The hemodynamic and electrophysiological action of the left HEART VENTRICLE. Its measurement is an important aspect of the clinical evaluation of patients with heart disease to determine the effects of the disease on cardiac performance. Left Ventricular Function,Function, Left Ventricular,Functions, Left Ventricular,Left Ventricular Functions,Ventricular Functions, Left

Related Publications

Satoshi Matsushita, and Akinori Kishida, and Yoshihito Wakamatsu, and Hiroshi Mukaida, and Hirohide Yokokawa, and Taira Yamamoto, and Atsushi Amano
February 1983, The Journal of thoracic and cardiovascular surgery,
Satoshi Matsushita, and Akinori Kishida, and Yoshihito Wakamatsu, and Hiroshi Mukaida, and Hirohide Yokokawa, and Taira Yamamoto, and Atsushi Amano
July 1983, Annals of surgery,
Satoshi Matsushita, and Akinori Kishida, and Yoshihito Wakamatsu, and Hiroshi Mukaida, and Hirohide Yokokawa, and Taira Yamamoto, and Atsushi Amano
June 1998, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi,
Satoshi Matsushita, and Akinori Kishida, and Yoshihito Wakamatsu, and Hiroshi Mukaida, and Hirohide Yokokawa, and Taira Yamamoto, and Atsushi Amano
January 1981, Annals of surgery,
Satoshi Matsushita, and Akinori Kishida, and Yoshihito Wakamatsu, and Hiroshi Mukaida, and Hirohide Yokokawa, and Taira Yamamoto, and Atsushi Amano
October 1998, Anesthesia and analgesia,
Satoshi Matsushita, and Akinori Kishida, and Yoshihito Wakamatsu, and Hiroshi Mukaida, and Hirohide Yokokawa, and Taira Yamamoto, and Atsushi Amano
July 1992, The Journal of thoracic and cardiovascular surgery,
Satoshi Matsushita, and Akinori Kishida, and Yoshihito Wakamatsu, and Hiroshi Mukaida, and Hirohide Yokokawa, and Taira Yamamoto, and Atsushi Amano
January 1980, The Journal of thoracic and cardiovascular surgery,
Satoshi Matsushita, and Akinori Kishida, and Yoshihito Wakamatsu, and Hiroshi Mukaida, and Hirohide Yokokawa, and Taira Yamamoto, and Atsushi Amano
October 2012, Anesthesia and analgesia,
Satoshi Matsushita, and Akinori Kishida, and Yoshihito Wakamatsu, and Hiroshi Mukaida, and Hirohide Yokokawa, and Taira Yamamoto, and Atsushi Amano
June 1999, The journal of extra-corporeal technology,
Satoshi Matsushita, and Akinori Kishida, and Yoshihito Wakamatsu, and Hiroshi Mukaida, and Hirohide Yokokawa, and Taira Yamamoto, and Atsushi Amano
January 1986, The Journal of cardiovascular surgery,
Copied contents to your clipboard!